IDH3A and acute myeloid leukemia: Moreover, the driver mutations affecting isocitrate dehydrogenase (IDH)-1 and −2 genes are shown to result in accumulation of oncometabolite 2-hydroxyglutarate that has a prognostic value in acute myeloid leukemia (AML) [2,3].